Cargando…

The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study

BACKGROUND: In spite of high prevalence and clinical relevance of leukoaraiosis (LA), its pathophysiology is still incompletely understood. Theories of ischaemic genesis and a leaky blood–brain barrier are contradictory yet could share a common denominator–endothelial dysfunction (cerebral, systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zupan, Matija, Šabović, Mišo, Zaletel, Marjan, Popovič, Katarina Šurlan, Žvan, Bojana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557861/
https://www.ncbi.nlm.nih.gov/pubmed/26329797
http://dx.doi.org/10.1186/s12883-015-0416-z
_version_ 1782388531939770368
author Zupan, Matija
Šabović, Mišo
Zaletel, Marjan
Popovič, Katarina Šurlan
Žvan, Bojana
author_facet Zupan, Matija
Šabović, Mišo
Zaletel, Marjan
Popovič, Katarina Šurlan
Žvan, Bojana
author_sort Zupan, Matija
collection PubMed
description BACKGROUND: In spite of high prevalence and clinical relevance of leukoaraiosis (LA), its pathophysiology is still incompletely understood. Theories of ischaemic genesis and a leaky blood–brain barrier are contradictory yet could share a common denominator–endothelial dysfunction (cerebral, systemic or both), which has not been studied thoroughly in LA. METHODS: Thirty patients with LA (58 years (SD 7)) and 30 gender- and age-matched controls without LA (55 years (SD 6)) were recruited. The vascular risk factors (VRF) were identical in both groups. Cerebral endothelial function was determined by cerebrovascular reactivity to L-arginine (CVR). Systemic endothelial function was determined by flow-mediated dilatation (FMD) of the brachial artery after hyperaemia. All participants underwent a brain MRI to search for radiological signs of LA that was classified according to the Fazekas score. Linear regression was used to explore the correlation between CVR and FMD in patients with LA. A 95 % confidence interval was used. For any statistical test used in the study, p ≤ 0.050 was regarded as statistically significant. RESULTS: We found a marked and significant decrease in both CVR (9.6 % (SD 3.2) vs. 15.8 % (SD 6.1), p < 0.001) and FMD (4.8 % (SD 3.1) vs. 7.4 % (SD 3.8), p = 0.004) in LA patients compared to controls. Both CVR (7.4 % (SD 3.1) vs. 12.2 % (SD 2.6), p = 0.001) and FMD (3.0 % (SD 2.2) vs. 6.4 % (SD 3.1), p = 0.011) were significantly decreased in LA subgroup Fazekas 3 compared to subgroup Fazekas 1. CVR and FMD significantly positively correlated (b = 0.192, 95 % CI = 0.031–0.354, p = 0.02). CONCLUSIONS: The results of our pilot study suggest that patients with LA have a significant impairment of both cerebral and systemic endothelial function that is larger than could be expected based on present VRF. Endothelial dysfunction increases in parallel with LA severity and correlates between cerebral and systemic arterial territory. Overall, our results suggest a so far unknown “intrinsic” generalised endothelial dysfunction in patients with LA that could be involved in LA pathophysiology. This interesting issue needs to be confirmed in larger samples since it could help better understand the mechanisms underlying LA.
format Online
Article
Text
id pubmed-4557861
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45578612015-09-03 The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study Zupan, Matija Šabović, Mišo Zaletel, Marjan Popovič, Katarina Šurlan Žvan, Bojana BMC Neurol Research Article BACKGROUND: In spite of high prevalence and clinical relevance of leukoaraiosis (LA), its pathophysiology is still incompletely understood. Theories of ischaemic genesis and a leaky blood–brain barrier are contradictory yet could share a common denominator–endothelial dysfunction (cerebral, systemic or both), which has not been studied thoroughly in LA. METHODS: Thirty patients with LA (58 years (SD 7)) and 30 gender- and age-matched controls without LA (55 years (SD 6)) were recruited. The vascular risk factors (VRF) were identical in both groups. Cerebral endothelial function was determined by cerebrovascular reactivity to L-arginine (CVR). Systemic endothelial function was determined by flow-mediated dilatation (FMD) of the brachial artery after hyperaemia. All participants underwent a brain MRI to search for radiological signs of LA that was classified according to the Fazekas score. Linear regression was used to explore the correlation between CVR and FMD in patients with LA. A 95 % confidence interval was used. For any statistical test used in the study, p ≤ 0.050 was regarded as statistically significant. RESULTS: We found a marked and significant decrease in both CVR (9.6 % (SD 3.2) vs. 15.8 % (SD 6.1), p < 0.001) and FMD (4.8 % (SD 3.1) vs. 7.4 % (SD 3.8), p = 0.004) in LA patients compared to controls. Both CVR (7.4 % (SD 3.1) vs. 12.2 % (SD 2.6), p = 0.001) and FMD (3.0 % (SD 2.2) vs. 6.4 % (SD 3.1), p = 0.011) were significantly decreased in LA subgroup Fazekas 3 compared to subgroup Fazekas 1. CVR and FMD significantly positively correlated (b = 0.192, 95 % CI = 0.031–0.354, p = 0.02). CONCLUSIONS: The results of our pilot study suggest that patients with LA have a significant impairment of both cerebral and systemic endothelial function that is larger than could be expected based on present VRF. Endothelial dysfunction increases in parallel with LA severity and correlates between cerebral and systemic arterial territory. Overall, our results suggest a so far unknown “intrinsic” generalised endothelial dysfunction in patients with LA that could be involved in LA pathophysiology. This interesting issue needs to be confirmed in larger samples since it could help better understand the mechanisms underlying LA. BioMed Central 2015-09-02 /pmc/articles/PMC4557861/ /pubmed/26329797 http://dx.doi.org/10.1186/s12883-015-0416-z Text en © Zupan et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zupan, Matija
Šabović, Mišo
Zaletel, Marjan
Popovič, Katarina Šurlan
Žvan, Bojana
The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
title The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
title_full The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
title_fullStr The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
title_full_unstemmed The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
title_short The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
title_sort presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis - a case control pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557861/
https://www.ncbi.nlm.nih.gov/pubmed/26329797
http://dx.doi.org/10.1186/s12883-015-0416-z
work_keys_str_mv AT zupanmatija thepresenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy
AT sabovicmiso thepresenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy
AT zaletelmarjan thepresenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy
AT popovickatarinasurlan thepresenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy
AT zvanbojana thepresenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy
AT zupanmatija presenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy
AT sabovicmiso presenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy
AT zaletelmarjan presenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy
AT popovickatarinasurlan presenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy
AT zvanbojana presenceofcerebralandorsystemicendothelialdysfunctioninpatientswithleukoaraiosisacasecontrolpilotstudy